Physical

Gurnick Academy of Medical Arts' Student Awarded ABHES Scholarship

Retrieved on: 
Tuesday, March 29, 2022

SAN MATEO, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- A Gurnick Academy of Medical Arts student was awarded the 7th-annual Christopher J. Eaton Scholarship Award for 2022 by the Accrediting Bureau of Health Education Schools (ABHES).

Key Points: 
  • SAN MATEO, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- A Gurnick Academy of Medical Arts student was awarded the 7th-annual Christopher J. Eaton Scholarship Award for 2022 by the Accrediting Bureau of Health Education Schools (ABHES).
  • Samantha Phee, a third-term Physical Therapy Assistant (PTA) program student from the San Mateo Campus, received this year's scholarship atthe18th-Annual National Conference on Allied Health Education.
  • Those of us present from Gurnick Academy of Medical Arts were very proud as Samantha delivered a beautiful and heartfelt speech.
  • Gurnick Academy of Medical Arts is a private, post-secondary educational institution operating six campuses across California.

Alexandra Cattelan Named Chief Technology Officer – Brunswick Corporation

Retrieved on: 
Monday, March 28, 2022

METTAWA, Ill., March 28, 2022 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) announced today that it has appointed Alexandra Cattelan as its Chief Technology Officer, effective immediately.

Key Points: 
  • METTAWA, Ill., March 28, 2022 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) announced today that it has appointed Alexandra Cattelan as its Chief Technology Officer, effective immediately.
  • Cattelan will be responsible for continuing to advance Brunswicks ACES strategy and, more generally, for maintaining Brunswicks position of technology leadership in the marine industry.
  • Prior to joining Polaris, Cattelan held a number of leadership positions in the automotive industry developing advanced electrified mobility solutions.
  • I am thrilled to join Brunswick at such an exciting time in the Companys history, said Cattelan.

NeuFit® Introduces Cullen Nigrini as Clinical Director and Head of Sports Medicine

Retrieved on: 
Thursday, March 31, 2022

AUSTIN, Texas , March 31, 2022 /PRNewswire/ -- NeuFit ®, a provider of advanced neuromuscular treatment for athletes and rehabilitation patients, has hired Cullen Nigrini, PT, SCS, OCS, AT to lead the clinic at the company's Westlake headquarters. Nigrini was most recently a physical therapist with the New Orleans Pelicans and the University of Texas Longhorns athletics program as well as owner of his own physical therapy practice in Austin.

Key Points: 
  • Nigrini is Austin's first physical therapist to receive board certification in both orthopedic and sports physical therapy through the American Board of Physical Therapy Specialists.
  • "NeuFit is changing sports medicine by applying powerful neurological principles and advanced technology into daily practice," said Nigrini.
  • I am very excited about the impact we can make here in Austin and in the larger sports medicine community."
  • Neubie and NeuFit are registered trademarks of NeuFit.

Vigil Neuroscience Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

Retrieved on: 
Friday, March 25, 2022

CAMBRIDGE, Mass., March 25, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced financial results for the fourth quarter and full year ended December 31, 2021 and provided an update on recent business highlights.

Key Points: 
  • The gross proceeds of the offering were $98 million, before deducting underwriting discounts and commissions and other offering expenses.
  • 11,186,636, which describes the VGL101 antibody and claims compositions of matter, pharmaceutical compositions and methods of production, each directed to the VGL101 antibody.
  • This underpins the Companys anti-TREM2 antibody technology and provides Vigil with intellectual property protection.
  • As a result, 2020 financial reporting below represents only partial year results vs 2021 reporting which reflects 12 full months of operations.

Employer-Reported Respiratory Illness Increased 4,000% in 2020, Signaling Effects from COVID-19, Allsup Reports

Retrieved on: 
Monday, March 21, 2022

In a report from the U.S. Bureau of Labor Statistics, the number of respiratory cases rose from 10,800 in 2019 to 428,700 in 2020.

Key Points: 
  • In a report from the U.S. Bureau of Labor Statistics, the number of respiratory cases rose from 10,800 in 2019 to 428,700 in 2020.
  • Respiratory illnesses comprised 79% of all employer-reported illnesses in 2020 compared to 8.5% in 2019.
  • This enormous spike in reported cases of respiratory illnesses strongly suggests the impact of the COVID-19 pandemic, said T.J. Geist, Principal Advocate for Allsup.
  • As weve come to understand in these past two years, the coronavirus and its variants have serious implications for the lungs and overall respiratory system.

ASICS Experiment Reveals Just One Week of Physical Inactivity Has a Similar Impact as a Week of Broken Sleep on Our State of Mind

Retrieved on: 
Wednesday, March 30, 2022

The impact on their state of mind was found to be similar to a week of broken sleepii, with participants reporting a 23% increase in racing thoughts.

Key Points: 
  • The impact on their state of mind was found to be similar to a week of broken sleepii, with participants reporting a 23% increase in racing thoughts.
  • The effects of this inactivity are captured in the Mind Race experiment film asics.com/mindrace , following a group of study participants.
  • The Study uses cutting edge technology to mimic EEG and capture the impact of exercise on peoples state of mind.
  • Based on data from across sports and across regions, just 15.09 minutes of exercise can significantly impact our mental state.

Endava Launches Operations in Canada Building on its North America Momentum

Retrieved on: 
Wednesday, March 23, 2022

Endava plc (NYSE: DAVA), a global provider of digital transformation, agile development, and intelligent automation services, today announced the establishment of its first operations in Canada.

Key Points: 
  • Endava plc (NYSE: DAVA), a global provider of digital transformation, agile development, and intelligent automation services, today announced the establishment of its first operations in Canada.
  • Providing close-to-client expertise, alongside our leading distributed agile delivery model, has proven to be a winning combination for clients and for Endava, said Chris Hart, EVP, Client Success, North America, Endava.
  • As a global provider of technology and services, Endava has a well-earned reputation as a leader in supporting clients in the financial services and payments sectors.
  • Endava services clients in Payments and Financial Services, TMT, Consumer Products, Retail, Mobility and Healthcare.

FirstEnergy Promotes Ernest N. Maley to Vice President & Chief Information Officer

Retrieved on: 
Monday, March 28, 2022

AKRON, Ohio, March 28, 2022 /PRNewswire/ -- FirstEnergy Corp. (NYSE: FE) today announced that Ernest (Ernie) N. Maley has been promoted to vice president and chief information officer, effective April 10, 2022.

Key Points: 
  • AKRON, Ohio, March 28, 2022 /PRNewswire/ -- FirstEnergy Corp. (NYSE: FE) today announced that Ernest (Ernie) N. Maley has been promoted to vice president and chief information officer, effective April 10, 2022.
  • Maley will report to Sam Belcher, senior vice president, Operations.
  • Maley was promoted to vice president of IT Operations in 2011 and became vice president, IT Solutions, in 2015.
  • He was named vice president, Information Technology Operations in 2016 and most recently served as vice president, IT, Innovation and Enablement.

SENSTAR SYMPHONY™ SENSOR FUSION ENGINE WINS SECURITY INDUSTRY ASSOCIATION NEW PRODUCTS & SOLUTIONS AWARD AT ISC WEST

Retrieved on: 
Monday, March 28, 2022

RAMAT GAN, Israel, March 28, 2022 /PRNewswire/ -- Senstar Corp. a Senstar Technologies' subsidiary (NASDAQ: SNT) and a global provider of video management and perimeter intrusion detection solutions, is pleased to announce its Senstar Symphony Sensor Fusion Engine has been awarded a Security Industry Association (SIA) New Products & Solutions Award.

Key Points: 
  • RAMAT GAN, Israel, March 28, 2022 /PRNewswire/ -- Senstar Corp. a Senstar Technologies' subsidiary (NASDAQ: SNT) and a global provider of video management and perimeter intrusion detection solutions, is pleased to announce its Senstar Symphony Sensor Fusion Engine has been awarded a Security Industry Association (SIA) New Products & Solutions Award.
  • The Senstar Symphony Sensor Fusion Engine is a breakthrough technology that synthesizes data from separate systems to generate actionable information.
  • "The Senstar Symphony Sensor Fusion Engine addresses two of the top concerns for perimeter securityreducing nuisance alarms and increasing the probability of detection," said Senstar Corp.
  • The Senstar Symphony Sensor Fusion Engine is part of the Senstar Symphony Common Operating Platform amodular solution for security management and data intelligence.

Galderma Launches TWYNEO® Cream, the First Ever Tretinoin and Benzoyl Peroxide Combination to Treat Facial Acne

Retrieved on: 
Friday, March 25, 2022

"TWYNEO Cream may help teens with acne especially the boys struggling with generic tretinoin or adhering to complex treatment routines, since it's a once-daily, potent combination that can be used any time of day."

Key Points: 
  • "TWYNEO Cream may help teens with acne especially the boys struggling with generic tretinoin or adhering to complex treatment routines, since it's a once-daily, potent combination that can be used any time of day."
  • A month's supply of TWYNEO Cream costs $0 for commercially covered patients or $60 for uninsured patients with the Galderma CAREConnect savings card.
  • TWYNEO Cream may cost less than generic tretinoin alone when using the Galderma CAREConnect savings card.
  • Indication:TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1%/3% is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older.